Mode
Text Size
Log in / Sign up
N/A Completed N=12 Supportive Care

Low-Level Laser in Treatment of Head and Neck Lymphedema: A Pilot Study

Source: ClinicalTrials.gov NCT03738332 ↗
Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Jan 2022
Primary outcomePrimary: Number of Participants Consented and Enrolled in Study — 12 Participants

Summary

The purpose of this pilot clinical trial is to evaluate the feasibility of the use of low-level laser for head and neck cancer survivors with lymphedema.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Consented and Enrolled in Study
12
PRIMARY
Number of Participants Completed the Study Visits
11
PRIMARY
Number of Participants With Adverse Events
PRIMARY
Number of Participants Who Were Satisfied With Study Intervention.
11

Eligibility Criteria

Inclusion Criteria

  • >18 years of age
  • Completion of either postoperative radiation or chemoradiation therapy
  • No evidence of cancer
  • Having head and neck external lymphedema
  • Either completion of lymphedema therapy or not in active lymphedema therapy
  • Ability to speak and read English
  • Able to provide informed consent

Exclusion Criteria

Patients will be excluded if they have any of the following medical conditions that would prohibit the safe implementation of LLLT: pregnancy; photosensitivity; chronic inflammatory diseases; venous thrombosis; history of severe trauma; medication that affects body fluid and electrolyte balance; use of high doses of non-steroidal anti-inflammatory drugs; or pre-existing skin rash, ulceration, open wound in the treatment area; and allergic and other systemic skin diseases.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03738332). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search